- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Phone consultations
Last updated: 29 Jun 2020
- Upper GI
- Home chemotherapy
Dr Hubner received undergraduate medical training at Cambridge and Oxford Universities, and completed specialist training in medical oncology at the Royal Marsden Hospital. Dr Hubner performed research into genetic susceptibility to cancer leading to a PhD, and this and other research has led to a number of publications in peer-reviewed medical journals and presentations at national and international meetings.
Dr Hubner has been a consultant at the Christie NHS Foundation Trust since 2010, and is currently Principle Investigator or Co-Investigator for a number of phase II and III clinical trials of novel therapies for patients with upper GI, hepatopancreaticobiliary and neuroendocrine cancers.
Areas of interest
Systemic therapies for oesophageal and gastric cancers, pancreas and bile duct cancers, gallbladder cancer, hepatocellular carcinoma (HCC), and neuroendocrine cancers
Current NHS consultant posts held
The Christie NHS Foundation Trust
Clinical trials in both early and advanced cancer settings, identification of factors which predict efficacy and toxicity of therapies, towards personalised anti-cancer treatment.
- PhD University of London 2008
- MA Cambridge University 1995
- BM BCh Oxford University 1998
Reference number 4530419
Details of entry to specialist register
- Medical Oncology, 2010
Affiliations / memberships
General Medical Council
Royal College of Physicians Association of Cancer Physicians
Association of Cancer Physicians, UK
American Society of Clinical Oncology
United Kingdom and Ireland Neuroendocrine Tumour Society
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.